Lack of efficacy (bacteria) - Bordetella

Verify with FDA CVM →

VeDDRA Code: 3013

37 adverse event reports referencing this reaction

37
Total Reports
2
Deaths
540.0%
Death Rate

Species Most Affected

Dog 36
Cat 1

Breeds Most Affected

Retriever - Golden 5
Shepherd Dog - German 4
Retriever - Labrador 3
Boxer (German Boxer) 2
Terrier (unspecified) 2
Terrier - Boston 2
Pit Bull 2
Pug 2
Setter - English 2
Shepherd Dog - Australian 2

Associated Drugs

Oral Bordetella Canine - 1081.01 10
Bordetella Bronchiseptica Vaccine, Avirulent Live Culture 10
Lotilaner 8
Milbemycin Oxime + Praziquantel 8
Ivermectin + Pyrantel As Pamoate Salt 7
Afoxolaner 5
Bordetella Bronchiseptica, Boehringer Ingelheim Strain 5
Enrofloxacin 4
Rabies Vaccine 4
Maropitant Citrate 3
Doxycycline 3
Fluralaner 13.64% 12-Week Chew 2
Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim 2
Benazepril 2
Oclacitinib Maleate 2
Bordetella Bronchiseptica B-C2 2
Estriol Tablets 2
Trimeprazine Tartrate + Prednisolone 2
Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine, Mlv, Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract 2
Grapiprant 2

Data Summary

Metric Value
Total reports referencing reaction 37
Reports with fatal outcome 2
Case-fatality rate (reported events) 540.0%
Species observed 2
Breeds observed 20
Drugs associated with reaction 20

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER); reaction term coded under VeDDRA 3013.

Lack of efficacy (bacteria) - Bordetella Reaction Insights

The FDA Center for Veterinary Medicine database currently lists 37 adverse event reports that reference Lack of efficacy (bacteria) - Bordetella as a reaction term, including 2 reports with a death outcome — a 540.0% case-fatality figure calculated across only those events where this reaction was coded. The reaction is indexed in the openFDA system under VeDDRA code 3013, the standardized veterinary dictionary used to normalize clinical signs across submitters. Because reports are voluntary and often describe multiple concurrent signs per animal, the volume here reflects reporting intensity rather than true incidence in the broader pet population.

Lack of efficacy (bacteria) - Bordetella appears most frequently in reports for Dog (36 reports), Cat (1 reports) — with Dog dominating at 36 entries. Within those species, the breeds most often named alongside this reaction are Retriever - Golden (5), Shepherd Dog - German (4), Retriever - Labrador (3). These distributions are influenced both by underlying breed popularity and by how veterinarians and owners code a given clinical sign, so they should be interpreted as a reporting fingerprint rather than a pure susceptibility ranking.

The drugs most commonly co-reported with Lack of efficacy (bacteria) - Bordetella are Oral Bordetella Canine - 1081.01 (10 reports), Bordetella Bronchiseptica Vaccine, Avirulent Live Culture (10 reports), Lotilaner (8 reports), Milbemycin Oxime + Praziquantel (8 reports), with Oral Bordetella Canine - 1081.01 appearing alongside this reaction in 10 submissions. Co-reporting does not establish that any specific product caused the reaction — FDA CVM data captures temporal association only. The value of these aggregates is in flagging which therapeutic classes appear repeatedly alongside a given clinical sign, so owners and veterinarians can ask targeted questions about medications currently in use.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial